research

  1. Katelyn Baker

    Quantifying Weed - Why We Need More Data On Our Dank

    This November, voters in at least nine states will be heading to the polling stations to decide on whether they will be joining the four states where marijuana is already legal or the 25 states and Washington, D.C.,where it has been okayed for medicinal use. But even if all nine states pass...
  2. Katelyn Baker

    Virginia Tech Participates In State-Wide Research Project On Cultivating Hemp

    Over a year after the Virginia General Assembly passed a bill allowing certain institutions to grow hemp, seeds finally went into the ground this summer at Virginia Tech. Virginia House Bill 699 authorized the creation of the Industrial Hemp Research Program and set criteria for growing hemp...
  3. Katelyn Baker

    There Are Two Main Types Of Marijuana - Here's The Difference

    If you're new to marijuana, shopping at a dispensary can be an overwhelming experience. Typically, a menu board lists a dozen or more varieties, called strains, with names that sound like punch lines from a Seth Rogen movie. From the subdued Blue Dream to the upbeat and euphoric Berry White...
  4. Katelyn Baker

    The DEA Is Looking For Candidates To Grow Marijuana For Research

    Wanted: Someone to grow marijuana for the federal government. Benefits: A contract likely worth millions and the chance to enable medical research. Requirements: Ability to deal with the costs and regulations that come with growing an illegal drug for the federal government. For more than...
  5. Katelyn Baker

    CA: Pot Research Firms Say Prop 64 Would Spike Weed Sales

    Two groups studying the cannabis economy say legalizing recreational marijuana in California will provide a $1.6 billion boost in revenues from expanded retail marijuana sales. The projections on California's Proposition 64 legalization measure in November come from two firms with a vested...
  6. Katelyn Baker

    Washington Will Conduct Cannabis Research In Violation Of The Law

    Earlier this month, the DEA proved its utter detachment from reality — and its subservience to Big Pharma — by maintaining the classification of cannabis as a Schedule 1 drug. This means, according to their classification system, it has "no currently accepted medical use and a high potential for...
  7. Katelyn Baker

    Kentucky Ag Commissioner Reviewing Federal Hemp Opinion

    A federal opinion on industrial hemp research programs may provide new opportunities in Kentucky. The report, called a Statement of Principles on Industrial Hemp, released by the United States Department of Agriculture, Food and Drug Administration and Drug Enforcement Administration holds...
  8. Katelyn Baker

    Boom Of Medical Marijuana Research On The Horizon As DEA Loosens Restrictions

    Head of the Multidisciplinary Association for Psychedelic Studies (MAPS) Rick Doblin has been working on getting marijuana approved as a medicine for years, and recently announced the Drug Enforcement Administration (DEA) is starting to open up to the idea of licensing more than one producer of...
  9. Katelyn Baker

    Boom Of Medical Marijuana Research On The Horizon As DEA Loosens Restrictions

    Head of the Multidisciplinary Association for Psychedelic Studies (MAPS) Rick Doblin has been working on getting marijuana approved as a medicine for years, and recently announced the Drug Enforcement Administration (DEA) is starting to open up to the idea of licensing more than one producer of...
  10. Katelyn Baker

    Washington's Plans For Pot Research Going Forward, Despite Federal Rules

    Washington state is moving ahead with its plans to allow scientific research of marijuana, sidestepping federal rules that critics say have hampered study of the drug for decades. The state has a new marijuana research license that will allow laboratories to grow marijuana for scientific...
  11. Katelyn Baker

    After Years Of Quiet Progress, Israeli Medical Cannabis Research Is Budding

    Behind closed doors somewhere in the recesses of the Israeli government's Agricultural Research Organization, Dr. Nirit Bernstein has been working for the past three years to perfect cannabis cultivation practices. "It's difficult to be a cannabis researcher. It's much easier to be a tomato...
  12. Katelyn Baker

    After Years Of Quiet Progress, Israeli Medical Cannabis Research Is Budding

    Behind closed doors somewhere in the recesses of the Israeli government's Agricultural Research Organization, Dr. Nirit Bernstein has been working for the past three years to perfect cannabis cultivation practices. "It's difficult to be a cannabis researcher. It's much easier to be a tomato...
  13. Katelyn Baker

    CO: Marijuana Researchers Cautiously Optimistic About Future Of Cannabis

    The Drug Enforcement Administration seemingly squashed medical marijuana last week when it refused to reclassify the drug, mainly citing a lack of research supporting its benefits. The news was salt in a wound to researchers in Colorado who have been striving to do such studies but feel...
  14. Katelyn Baker

    CO: Marijuana Researchers Cautiously Optimistic About Future Of Cannabis

    The Drug Enforcement Administration seemingly squashed medical marijuana last week when it refused to reclassify the drug, mainly citing a lack of research supporting its benefits. The news was salt in a wound to researchers in Colorado who have been striving to do such studies but feel...
  15. Katelyn Baker

    DEA Ends Mississippi's Medical Marijuana Research Monopoly

    Countless activists, researchers and enthusiasts let out a collective whimper when the Drug Enforcement Administration upheld a 46-year-old policy of classifying marijuana as a Schedule I narcotic with no medicinal properties. But then, federal officials did something utterly unexpected and...
  16. Katelyn Baker

    DEA Ends Mississippi's Medical Marijuana Research Monopoly

    Countless activists, researchers and enthusiasts let out a collective whimper when the Drug Enforcement Administration upheld a 46-year-old policy of classifying marijuana as a Schedule I narcotic with no medicinal properties. But then, federal officials did something utterly unexpected and...
  17. Katelyn Baker

    CA: Coachella Pot CEO To Speak At "The End Of Opiates"

    The CEO of Coachella's first medical marijuana business will be helping to raise money to fund the University of California, Irvine's cannabis research team next week at The End of Opiates symposium. The event, which takes place at the Avenue of the Arts Hotel in Costa Mesa Aug. 26, will...
  18. Katelyn Baker

    CA: Coachella Pot CEO To Speak At "The End Of Opiates"

    The CEO of Coachella's first medical marijuana business will be helping to raise money to fund the University of California, Irvine's cannabis research team next week at The End of Opiates symposium. The event, which takes place at the Avenue of the Arts Hotel in Costa Mesa Aug. 26, will...
  19. Katelyn Baker

    CA: Coachella Pot CEO To Speak At "The End Of Opiates"

    The CEO of Coachella's first medical marijuana business will be helping to raise money to fund the University of California, Irvine's cannabis research team next week at The End of Opiates symposium. The event, which takes place at the Avenue of the Arts Hotel in Costa Mesa Aug. 26, will...
  20. Katelyn Baker

    The DEA Has Just Been 'Toying With Us' On Legalizing Marijuana

    Last week, the DEA decided not to reschedule the classification of marijuana as a legal drug. According to federal drug codes, cannabis is still as deadly and addictive as heroin, with no known medical value. I was surprised to see how many articles were written about this decision without...
Back
Top Bottom